<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33436">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01871519</url>
  </required_header>
  <id_info>
    <org_study_id>P12-03</org_study_id>
    <nct_id>NCT01871519</nct_id>
  </id_info>
  <brief_title>Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs</brief_title>
  <acronym>EVOLVE</acronym>
  <official_title>A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Spinal and Biologics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Spinal and Biologics</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The  study  objective  is  to  collect  and  report  12-month  outcomes pertaining to
      activities of daily living, quality of life, and safety parameters in a Medicare population
      to be treated with balloon kyphoplasty in the  treatment of painful, acute, vertebral  body
      compression fractures (VCFs) associated with either osteoporosis or cancer.   The primary
      objective is to show statistically significant improvement from baseline in the four
      co-primary endpoints (SF-36v2, PCS, EQ-5D, NRS back pain and ODI) at 3-months; study success
      will be declared if the primary objective is met.  New radiographic fractures, non-surgical
      management received, VCF-related healthcare resource utilization, and vertebral body height
      restoration data will also be collected.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change from baseline in back function by Oswestry Disability Index</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in back pain by Numerical Rating Scale</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in quality of life by SF-36v2 Physical Component Summary</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in quality of life by the EQ-5D</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Compression Fracture of Vertebral Body</condition>
  <condition>Osteoporosis</condition>
  <condition>Cancer.</condition>
  <arm_group>
    <arm_group_label>Balloon Kyphoplasty</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This group of patients will be treated with balloon kyphoplasty in  the treatment  of  painful,  acute  VCFs  associated with  either osteoporosis  or cancer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Balloon kyphoplasty</intervention_name>
    <description>The  devices  to  be  used  in  this  study  are  intended  for  percutaneous balloon kyphoplasty (BKP) and consist of the Kyphon® bone access needles and cannulae, inflatable bone tamps, curettes, polymethyl methacrylate  bone  cement  (PMMA)  bone  cements,  and  bone  filler devices.</description>
    <arm_group_label>Balloon Kyphoplasty</arm_group_label>
    <other_name>BKP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Identified as an appropriate candidate for BKP and should have made the choice to
             have the procedure.

          2. Must be Medicare Eligible (At least 65 years of age or otherwise eligible).

          3. Must have one to three target VCFs, located between T5 and L5, which are due to
             underlying primary or secondary osteoporosis or cancer.

          4. Cancer patients should not have had a change in chemotherapy regimen within the last
             month, nor should they have a planned change within the next month from time of
             enrollment, with the exception of changes in dose.

          5. All VCFs to be treated must have clinical pain symptoms (pain on palpation/percussion
             over the fractured vertebral body) that correlate with radiographic findings as
             follows:

               1. Height change:   An acute (≤ four month) change in VB height or morphology from
                  a previous x-ray, CT or MRI, with height loss at the anterior, middle or
                  posterior portion of the VB consistent with a worsening of one or more grades by
                  the Genant criteria20, OR

               2. Positive MRI or bone scan: VB shows hyperintense signal on STIR sequence MRI, or
                  target VB is positive on radionuclide bone scan.

          6. All VCFs to be treated must have an estimated fracture age of four months or less.

          7. Treatment of all target VCFs must be technically feasible and clinically appropriate
             for balloon kyphoplasty.

          8. Pre-treatment back pain by numerical rating scale (NRS) score must be ≥ 7 (0-10
             scale) and refractory to non-surgical management.

          9. Pre-treatment Oswestry Disability Index must be ≥30 (0 - 100 scale).

         10. Must have life expectancy of ≥ 12 months.

         11. Must declare availability for all study visits.

         12. Must be able to understand the risks and benefits of participating in the study and
             be willing to provide written informed consent.

         13. Must have the mental capacity necessary to comply with protocol requirements for the
             12- month duration of study.

        Exclusion Criteria:

          1. Vertebral body morphology or fracture configuration contraindicative of balloon
             kyphoplasty.

          2. VCFs due to high-energy trauma.

          3. Asymptomatic VCFs or prophylactic treatment of non-fractured vertebral bodies.

          4. VCFs accompanied at the same site by primary tumors of the bone (e.g., osteosarcoma),
             solitary plasmacytoma or osteoblastic tumors.

          5. Platelet count of &lt;20,000/uL as measured at the time of hospital admission for the
             procedure.

          6. Back pain due to causes other than acute fracture.

          7. VCF with  a clinically estimated  (based  on  radiographic evidence as  well  as
             patient history) age of fracture &gt; four months.

          8. VCF accompanied by objective evidence of secondary radiculopathy or neurologic
             compromise.

          9. VCFs with the need for spinal surgery beyond balloon kyphoplasty.

         10. Spinal cord compression or canal compromise requiring decompression.

         11. Significant   clinical   comorbidity   that   may   either   contra-indicate
             surgery or interfere with long-term data collection or follow-up.

         12. Pre-existing conditions contrary to balloon kyphoplasty such as:

               1. Allergy to any components (e.g., bone cement, contrast medium) of the balloon
                  kyphoplasty device/procedure.

               2. Active  or  incompletely  treated  infection  of  the  vertebral  column  or
                  active systemic infection, including unresolved urinary tract infection.

               3. Irreversible coagulopathy or bleeding disorder.

         13. Contraindications to both MRI and radionuclide bone scan.

         14. Concurrent participation in another clinical study.

         15. Pregnant or intending to become pregnant during the course of the study.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Clinical Department</last_name>
    <phone>1800-876-3133</phone>
    <phone_ext>6068</phone_ext>
    <email>msbkclinicalresearch@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alabama Clinical Therapeutics, LLC</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Jones</last_name>
      <phone>205-833-2228</phone>
    </contact>
    <investigator>
      <last_name>Bradly Goodman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Alabama at Birmingham, Division of Neurological Surgery</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meredith Owens</last_name>
      <phone>205-318-7950</phone>
    </contact>
    <investigator>
      <last_name>Melissa R. Chambers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington Radiologist Medical Group</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94538</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Russell Davis</last_name>
      <phone>510-745-6480</phone>
    </contact>
    <investigator>
      <last_name>Bruce H. Lin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sutter Health Sacramento Sierra Region</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Dyer</last_name>
      <phone>916-454-6962</phone>
    </contact>
    <investigator>
      <last_name>Mark Davidian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alta Orthopaedic Medical Group</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Yim</last_name>
      <phone>805-963-9377</phone>
    </contact>
    <investigator>
      <last_name>Stuart Hutchinson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Torrance Memorial Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaquelina Patti</last_name>
      <phone>310-257-5781</phone>
    </contact>
    <investigator>
      <last_name>George So, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radiology Imaging Specialist of Lakeland</name>
      <address>
        <city>Lakeland</city>
        <state>Florida</state>
        <zip>33805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robin Stewart</last_name>
      <phone>863-904-1877</phone>
    </contact>
    <investigator>
      <last_name>Venkat Tummala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Back Center</name>
      <address>
        <city>Melbourne</city>
        <state>Florida</state>
        <zip>32901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Sellati</last_name>
      <phone>321-541-1587</phone>
    </contact>
    <investigator>
      <last_name>Devin Datta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Physicians &amp; Surgeons of Pocatello</name>
      <address>
        <city>Blackfoot</city>
        <state>Idaho</state>
        <zip>83221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamara Roush</last_name>
      <phone>208-782-2953</phone>
    </contact>
    <investigator>
      <last_name>David Shelley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Illinois Neuroscience Foundation</name>
      <address>
        <city>Bloomington</city>
        <state>Illinois</state>
        <zip>61701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leslie Campbell</last_name>
      <phone>309-663-1522</phone>
    </contact>
    <investigator>
      <last_name>Ann R. Stroink, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Adventist Health Partners</name>
      <address>
        <city>Hinsdale</city>
        <state>Illinois</state>
        <zip>60521</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Mansell</last_name>
      <phone>708-245-8161</phone>
    </contact>
    <investigator>
      <last_name>Frank Facchini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presence Saint Joseph Medical Center</name>
      <address>
        <city>Joliet</city>
        <state>Illinois</state>
        <zip>60435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Paganessi</last_name>
      <phone>815-773-7031</phone>
    </contact>
    <investigator>
      <last_name>Joshua Tepper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Illinois Bone &amp; Joint</name>
      <address>
        <city>Morton Grove</city>
        <state>Illinois</state>
        <zip>60053</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriela Twardowski</last_name>
      <phone>847-324-3925</phone>
    </contact>
    <investigator>
      <last_name>Thomas F. Gleason, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana Spine Group</name>
      <address>
        <city>Carmel</city>
        <state>Indiana</state>
        <zip>46032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheetal Vinayek</last_name>
      <phone>317-715-5897</phone>
    </contact>
    <investigator>
      <last_name>Kevin Macadaeg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Diagnostic Imaging, PC</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48603</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Toevs</last_name>
      <phone>989-753-9000</phone>
    </contact>
    <investigator>
      <last_name>Sanjay Talati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Premier Radiology</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38802</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dennis Rowland</last_name>
      <phone>662-620-7111</phone>
    </contact>
    <investigator>
      <last_name>Jeffrey Howard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sierra Regional Spine Institute</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89509</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gayle Stevens</last_name>
      <phone>775-448-9432</phone>
    </contact>
    <investigator>
      <last_name>James Rappaport, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Consulting Orthopaedic Associates, Inc</name>
      <address>
        <city>Sylvania</city>
        <state>Ohio</state>
        <zip>43560</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Cordrey</last_name>
      <phone>419-517-7500</phone>
    </contact>
    <investigator>
      <last_name>Thomas Andreshak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Investigations, LLC</name>
      <address>
        <city>Edmond</city>
        <state>Oklahoma</state>
        <zip>73013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Witherby</last_name>
      <phone>405-601-2325</phone>
    </contact>
    <investigator>
      <last_name>Douglas Beall, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>James R. Webb, P.C.</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74133</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashleigh Dugan</last_name>
      <phone>918-630-0660</phone>
    </contact>
    <investigator>
      <last_name>James R. Webb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NeuroSpine Institute, LLC</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shawn Potts</last_name>
      <phone>541-284-0530</phone>
    </contact>
    <investigator>
      <last_name>Gregory A. Moore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scoliosis &amp; Spine Surgery Clinic of Memphis, PLLC</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38119</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Dickey</last_name>
      <phone>901-767-9500</phone>
    </contact>
    <investigator>
      <last_name>Douglas Linville, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 21, 2014</lastchanged_date>
  <firstreceived_date>June 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vertebral  body compression fracture</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Fractures, Compression</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
